Ncardia is a drug discovery company and expert in human IPSC technology. We operate worldwide with facilities, offices, and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture, and characterize high-quality IPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery. We listen to our customers' project plans, questions, and challenges, and co-develop human IPSC-based solutions that fit their specifications. Explore our website to learn more at www.ncardia.com.
Something looks off?